Menu
Menu
The world of health is vast and has diverse needs. At GAIKER, we offer solutions and support for the R&D of companies belonging to this sector, ranging from the development of systems for the detection of markers or targets of interest, to accompanying the development of drugs and medical devices. We have the knowledge, experience and state-of-the-art tools and equipment that enable us to add value to these activities by adapting to the needs of our customers.
We apply and combine various cellular and biomolecular technologies that enable us to generate biological models in the laboratory to study the performance of drugs and medical devices in a robust and reliable way.
We carry out customised studies of the action mechanisms of an active ingredient, using physiological models that we develop ourselves, as well as studies based on conventional protocols, following international guidelines in the field of safety. Since 1998, we have been carrying out ADME-Tox studies under the guarantee of Good Laboratory Practices (GLP), certified by the Ministry of Health and Social Policy.
We have models of the different physiological barriers and other systems of interest, such as the skin, the digestive system, blood, the respiratory system and the central nervous system.
On the other hand, GAIKER’s experience in immunochemistry, molecular biology, microbiology and enzymology enables us to develop rapid, portable, sensitive and low-cost detection systems to identify targets of interest as health markers.
The aim of GAIKER's involvement in this project is to develop a portable solution based on lateral flow technology for detecting exosome markers in urine that can be used as an easy-to-use tool for screening diseases at facilities with minimal laboratory equipment.
Subsidised by the Basque Government
The main aim of the project is to develop portable systems for detecting the Chikungunya virus that allow rapid diagnosis in the context of the problem of emerging pathogens that spread easily in a globalised world.
Diagnostic kit for the early detection of colorectal cancer (CRC) and advanced adenomas (AA) using a non-invasive method that is easy to use by non-specialists and does not require specific molecular biology facilities. The successful implementation of this kit will achieve faster diagnostic results and drastically reduce the costs of such diagnoses.
Co-funded by the European Regional Development Fund (ERDF) – aim: to promote technological development, innovation and quality research
The aim of the bioGUNE 2015 project is to understand the viral and cellular mechanisms that give rise to rare pathologies and diseases and to identify therapeutic targets that interfere with or abort these processes using advanced, high-performance technologies.
Subsidised by the Basque Government
Development of nanoparticles capable of detecting the location and well as eliminating tumours, with control release of the drug contained inside them.
No results found.
Subscribe to our newsletter
